Long-term Follow-up of GEN-003-002 Subjects for Efficacy and Immunogenicity

CompletedOBSERVATIONAL
Enrollment

140

Participants

Timeline

Start Date

September 16, 2016

Primary Completion Date

July 14, 2017

Study Completion Date

July 14, 2017

Conditions
Genital Herpes Simplex Type 2
Interventions
BIOLOGICAL

Observational

Trial Locations (13)

15213

Magee - Women's Hospital of UPMC, Pittsburgh

27599

University of North Carolina, Chapel Hill

35294

University of Alabama - Birmingham, Birmingham

45229

Cincinnati Children's Hospital Medical Center, Cincinnati

46202

Indiana University, Indianapolis

60612

University of Illinois - Chicago, Chicago

77004

Center for Clinical Studies, Houston

78745

Tekton Research, Austin

92108

Medical Center for Clinical Research, San Diego

94115

Quest Clinical Research, San Francisco

97210

NW Dermatology and Research, Portland

98104

University of Washington, Seattle

02215

The Fenway Institute, Boston

Sponsors
All Listed Sponsors
lead

Genocea Biosciences, Inc.

INDUSTRY